두개내압 모니터링 디바이스 시장 규모, 점유율, 동향 분석 리포트 : 기술별, 용도별, 지역별, 부문 예측(2025-2030년)

Intracranial Pressure Monitoring Devices Market Growth & Trends:

The global intracranial pressure monitoring devices market is anticipated to reach USD 2.85 billion by 2030 and is anticipated to expand at a CAGR of 7.9% from 2025 to 2030, according to a new report by Grand View Research, Inc. The primary driving factors for market growth are the increasing adoption of minimally invasive surgeries, high demand in trauma care, and technological advancements.

Increasing focus of healthcare service providers on adopting sophisticated devices and technology solutions, and growth in healthcare expenditure across multiple regions are expected to generate lucrative opportunities. Demand for effective health management techniques and the growing requirement for solutions associated with critical care offered for patients experiencing complex conditions related to the brain or spinal cord has been stimulating innovation and technological advancements. Significant investments in research and development activities by organizations and governments, inclination among key players to develop novel products powered by modern technology capabilities, and increasing trauma or injury-driven treatments are anticipated to create further growth.

Intracranial Pressure Monitoring Devices Market Report Highlights:

• The invasive intracranial pressure monitoring devices segment dominated the global industry. It accounted for a revenue share of more than 75.0% in 2024, owing to the accuracy offered by techniques, and the requirement of adequate device placements in critical care.
• Non-invasive intracranial pressure monitoring devices segment is expected to experience the fastest CAGR of 10.0% during the forecast period.
• Transcranial Doppler Ultrasonography devices are anticipated to experience significant growth from 2025 to 2030.
• The Traumatic Brain Injury (TBI) segment held the largest revenue share in 2024.
• North America dominated the global industry in 2024, owing to the presence of sophisticated healthcare systems in countries such as the U.S. and Canada, growing incidence of trauma-driven injuries and strokes, and rising demand for non-invasive healthcare technologies.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Technique
  • 1.2.2. Application
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
  • 1.4.3. Secondary Sources
  • 1.4.4. Primary Research
• 1.5. Information or Data Analysis
  • 1.5.1. Data Analysis Models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
• 1.8. List of Secondary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Technique Outlook
  • 2.2.2. Application Outlook
  • 2.2.3. Regional Outlook
• 2.3. Competitive Insights

Chapter 3. Global Intracranial Pressure Monitoring Devices Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Global Intracranial Pressure Monitoring Devices Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
    • 3.3.1.1. Supplier Power
    • 3.3.1.2. Buyer Power
    • 3.3.1.3. Substitution Threat
    • 3.3.1.4. Threat of New Entrants
    • 3.3.1.5. Competitive Rivalry
  • 3.3.2. PESTLE Analysis

Chapter 4. Global Intracranial Pressure Monitoring Devices Market: Technique Business Analysis

• 4.1. Technique Segment Dashboard
• 4.2. Intracranial Pressure Monitoring Devices Market: Technique Movement Analysis
• 4.3. Global Intracranial Pressure Monitoring Devices Market Size & Trend Analysis, By Technique, 2018 to 2030 (USD Million)
• 4.4. Invasive
  • 4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.4.2. External Ventricular Drainage (EVD)
    • 4.4.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.4.3. Microtransducer ICP Monitoring
    • 4.4.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.4.4. Non-invasive
    • 4.4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.4.5. Transcranial Doppler Ultrasonography
    • 4.4.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.4.6. Tympanic Membrane Displacement (TMD)
    • 4.4.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.4.7. Optic Nerve Sheath Diameter
    • 4.4.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.4.8. MRI/CT
    • 4.4.8.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.4.9. Fundoscopy
    • 4.4.9.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 5. Global Intracranial Pressure Monitoring Devices Market: Application Business Analysis

• 5.1. Application Segment Dashboard
• 5.2. Intracranial Pressure Monitoring Devices Market: Application Movement Analysis
• 5.3. Global Intracranial Pressure Monitoring Devices Market Size & Trend Analysis, By Application, 2018 to 2030 (USD Million)
• 5.4. Traumatic Brain Injury
  • 5.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 5.5. Intracerebral Hemorrhage
  • 5.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 5.6. Meningitis
  • 5.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 5.7. Subarachnoid Hemorrhage
  • 5.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 5.8. CSF Management
  • 5.8.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 5.9. Migraine
  • 5.9.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 5.10. Stroke
  • 5.10.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 5.11. Hydrocephalus
  • 5.11.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 5.12. EEG
  • 5.12.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 5.13. Others
  • 5.13.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 6. Global Intracranial Pressure Monitoring Devices Market: Regional Estimates & Trend Analysis

• 6.1. Regional Market Dashboard
• 6.2. Regional Market Share Analysis, 2024 & 2030
• 6.3. Global Intracranial Pressure Monitoring Devices Market by Region: Key Takeaways
• 6.4. North America
  • 6.4.1. U.S.
    • 6.4.1.1. Key Country Dynamics
    • 6.4.1.2. Regulatory Framework/ Reimbursement Structure
    • 6.4.1.3. Competitive Scenario
    • 6.4.1.4. U.S. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.4.2. Canada
    • 6.4.2.1. Key Country Dynamics
    • 6.4.2.2. Regulatory Framework/ Reimbursement Structure
    • 6.4.2.3. Competitive Scenario
    • 6.4.2.4. Canada Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.4.3. Mexico
    • 6.4.3.1. Key Country Dynamics
    • 6.4.3.2. Regulatory Framework/ Reimbursement Structure
    • 6.4.3.3. Competitive Scenario
    • 6.4.3.4. Mexico Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 6.5. Europe
  • 6.5.1. Germany
    • 6.5.1.1. Key Country Dynamics
    • 6.5.1.2. Regulatory Framework/ Reimbursement Structure
    • 6.5.1.3. Competitive Scenario
    • 6.5.1.4. Germany Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.5.2. UK
    • 6.5.2.1. Key Country Dynamics
    • 6.5.2.2. Regulatory Framework/ Reimbursement Structure
    • 6.5.2.3. Competitive Scenario
    • 6.5.2.4. UK Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.5.3. France
    • 6.5.3.1. Key Country Dynamics
    • 6.5.3.2. Regulatory Framework/ Reimbursement Structure
    • 6.5.3.3. Competitive Scenario
    • 6.5.3.4. France Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.5.4. Italy
    • 6.5.4.1. Key Country Dynamics
    • 6.5.4.2. Regulatory Framework/ Reimbursement Structure
    • 6.5.4.3. Competitive Scenario
    • 6.5.4.4. Italy Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.5.5. Spain
    • 6.5.5.1. Key Country Dynamics
    • 6.5.5.2. Regulatory Framework/ Reimbursement Structure
    • 6.5.5.3. Competitive Scenario
    • 6.5.5.4. Spain Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.5.6. Russia
    • 6.5.6.1. Key Country Dynamics
    • 6.5.6.2. Regulatory Framework/ Reimbursement Structure
    • 6.5.6.3. Competitive Scenario
    • 6.5.6.4. Denmark Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 6.6. Asia Pacific
  • 6.6.1. Japan
    • 6.6.1.1. Key Country Dynamics
    • 6.6.1.2. Regulatory Framework/ Reimbursement Structure
    • 6.6.1.3. Competitive Scenario
    • 6.6.1.4. Japan Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.6.2. China
    • 6.6.2.1. Key Country Dynamics
    • 6.6.2.2. Regulatory Framework/ Reimbursement Structure
    • 6.6.2.3. Competitive Scenario
    • 6.6.2.4. China Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.6.3. India
    • 6.6.3.1. Key Country Dynamics
    • 6.6.3.2. Regulatory Framework/ Reimbursement Structure
    • 6.6.3.3. Competitive Scenario
    • 6.6.3.4. India Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.6.4. Australia
    • 6.6.4.1. Key Country Dynamics
    • 6.6.4.2. Regulatory Framework/ Reimbursement Structure
    • 6.6.4.3. Competitive Scenario
    • 6.6.4.4. Australia Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.6.5. Thailand
    • 6.6.5.1. Key Country Dynamics
    • 6.6.5.2. Regulatory Framework/ Reimbursement Structure
    • 6.6.5.3. Competitive Scenario
    • 6.6.5.4. Thailand Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.6.6. South Korea
    • 6.6.6.1. Key Country Dynamics
    • 6.6.6.2. Regulatory Framework/ Reimbursement Structure
    • 6.6.6.3. Competitive Scenario
    • 6.6.6.4. South Korea Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.6.7. Singapore
    • 6.6.7.1. Key Country Dynamics
    • 6.6.7.2. Regulatory Framework/ Reimbursement Structure
    • 6.6.7.3. Competitive Scenario
    • 6.6.7.4. South Korea Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 6.7. Latin America
  • 6.7.1. Brazil
    • 6.7.1.1. Key Country Dynamics
    • 6.7.1.2. Regulatory Framework/ Reimbursement Structure
    • 6.7.1.3. Competitive Scenario
    • 6.7.1.4. Brazil Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.7.2. Colombia
    • 6.7.2.1. Key Country Dynamics
    • 6.7.2.2. Regulatory Framework/ Reimbursement Structure
    • 6.7.2.3. Competitive Scenario
    • 6.7.2.4. Colombia Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.7.3. Argentina
    • 6.7.3.1. Key Country Dynamics
    • 6.7.3.2. Regulatory Framework/ Reimbursement Structure
    • 6.7.3.3. Competitive Scenario
    • 6.7.3.4. Argentina Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 6.8. Middle East & Africa
  • 6.8.1. South Africa
    • 6.8.1.1. Key Country Dynamics
    • 6.8.1.2. Regulatory Framework/ Reimbursement Structure
    • 6.8.1.3. Competitive Scenario
    • 6.8.1.4. South Africa Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.8.2. Saudi Arabia
    • 6.8.2.1. Key Country Dynamics
    • 6.8.2.2. Regulatory Framework/ Reimbursement Structure
    • 6.8.2.3. Competitive Scenario
    • 6.8.2.4. South Arabia Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.8.3. UAE
    • 6.8.3.1. Key Country Dynamics
    • 6.8.3.2. Regulatory Framework/ Reimbursement Structure
    • 6.8.3.3. Competitive Scenario
    • 6.8.3.4. UAE Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.8.4. Kuwait
    • 6.8.4.1. Key Country Dynamics
    • 6.8.4.2. Regulatory Framework/ Reimbursement Structure
    • 6.8.4.3. Competitive Scenario
    • 6.8.4.4. Kuwait Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis, By Key Market Participants
• 7.2. Company/Competition Categorization
• 7.3. Vendor Landscape
  • 7.3.1. Key Company Heat Map Analysis, 2024
• 7.4. Company Profiles
  • 7.4.1. Medtronic
    • 7.4.1.1. Company Overview
    • 7.4.1.2. Financial Performance
    • 7.4.1.3. Product Benchmarking
    • 7.4.1.4. Strategic Initiatives
  • 7.4.2. Integra LifeSciences
    • 7.4.2.1. Company Overview
    • 7.4.2.2. Financial Performance
    • 7.4.2.3. Product Benchmarking
    • 7.4.2.4. Strategic Initiatives
  • 7.4.3. RAUMEDIC AG
    • 7.4.3.1. Company Overview
    • 7.4.3.2. Financial Performance
    • 7.4.3.3. Product Benchmarking
    • 7.4.3.4. Strategic Initiatives
  • 7.4.4. Sophysa
    • 7.4.4.1. Company Overview
    • 7.4.4.2. Financial Performance
    • 7.4.4.3. Product Benchmarking
    • 7.4.4.4. Strategic Initiatives
  • 7.4.5. Spiegelberg GmbH & Co. KG. (Luciole Medical AG)
    • 7.4.5.1. Company Overview
    • 7.4.5.2. Financial Performance
    • 7.4.5.3. Product Benchmarking
    • 7.4.5.4. Strategic Initiatives
  • 7.4.6. Natus Medical
    • 7.4.6.1. Company Overview
    • 7.4.6.2. Financial Performance
    • 7.4.6.3. Product Benchmarking
    • 7.4.6.4. Strategic Initiatives
  • 7.4.7. Digitimer Ltd
    • 7.4.7.1. Company Overview
    • 7.4.7.2. Financial Performance
    • 7.4.7.3. Product Benchmarking
    • 7.4.7.4. Strategic Initiatives
  • 7.4.8. NeuraSignal, Inc.
    • 7.4.8.1. Company Overview
    • 7.4.8.2. Financial Performance
    • 7.4.8.3. Product Benchmarking
    • 7.4.8.4. Strategic Initiatives